Risk factor
Strong & resilient to price shocks
Profitability factor
Greatly overvalued vs peers
About
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). Its E&S segment delivers essential products for pharmaceutical manufacturing, including high-tech isolators, integrated automated systems, aseptic filling solutions, and specialized laboratory and cleanroom equipment. Meanwhile, the S&C segment focuses on providing comprehensive life cycle support, ready-to-use consumables, and custom digital and client-specific solutions. Founded in 1968, the company, which changed its name from BV Holding AG to SKAN Group AG in October 2021, is headquartered in Allschwil, Switzerland.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of SKAN.SW is 70.1 and suggests 0.863% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation